Independent Bank Group (IBTX) to Join S&P SmallCap 600

Independent Bank Group Inc. (NASD: IBTX) will replace Progenics Pharmaceuticals Inc. (NASD: PGNX) in the S&P SmallCap 600 effective prior to the opening of trading on Monday, June 22. S&P Small-Cap 600 constituent Lantheus Holdings Inc. (NASD: LNTH) is acquiring Progenics Pharmaceuticals in a deal expected to be completed on or about June 19 pending final conditions. Post-acquisition, Lantheus Holdings will remain in S&P SmallCap 600.

Independent Bank Group provides various commercial banking products and services. Headquartered in McKinney, TX the company will be added to the S&P SmallCap 600 GICS (Global Industry Classification Standard) Regional Banks Sub-Industry index.

Following is a summary of the change:

For more information about S&P Dow Jones Indices, please visit www.spdji.com

You May Also Be Interested In

• Korro Bio (KRRO) Announces $70M Placement
• Intelligent Bio Solutions (INBS) Reports Prelim Q3 Results
• Kartoon Studios (TOON) Prices 7M Share Offering at $1/sh